A. Lavolé

3.4k citations
110 papers · 2.5k · 1 hit paper · h-index 27

Impact in

  • Oncology top 2%
    • Viral-associated cancers and disorders
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Polyomavirus and related diseases
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Viral-associated cancers and disorders 26
    • Lung Cancer Research Studies 17
    • Cancer Immunotherapy and Biomarkers 15
    • Polyomavirus and related diseases 8
    • Colorectal Cancer Treatments and Studies 8
    • Lung Cancer Treatments and Mutations 38
    • Lung Cancer Diagnosis and Treatment 26

A. Lavolé

105 papers receiving 2.4k citations

A. Lavolé's Hit Papers

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial 2011 · 440 citations
4400+5+10Years since publication100200300400

Peers

A. Lavolé
Comparison fields: 5 of 86
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.1k
  • Virology 84
  • Genetics 174
  • Geriatrics and Gerontology 50
Replace Savina M. Luciana Aversa with:
Savina M. Luciana Aversa Italy
J.M. Tourani France
Domenico Errante Italy
Felicitas Hitz Switzerland
Lawrence Leichman United States
Patrizio Mazza Italy
Kentaro Imai Japan
Vincenzo De Lisi Italy
Bhupinder Sharma United Kingdom
Moshe Chaim Ornstein United States
A. Lavolé relative to Savina M. Luciana Aversa Italy Savina M. Luciana Aversa's profile →
Citations per field
00.5×5×10×15×21×
Savina M. Luciana Aversa · 1×
Citations per year

Countries citing papers authored by A. Lavolé

Since Specialization
Citations

This map shows the geographic impact of A. Lavolé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lavolé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lavolé more than expected).

Fields of papers citing papers by A. Lavolé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lavolé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lavolé. The network helps show where A. Lavolé may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Lavolé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Lavolé Line = papers co-authored together A. Lavolé links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
Hit paper breakdown →
2011440
2 2007147
3 202290
4 201389
5 200985
6 201585
7 201981
8 200673
9 201772
10 201469
11 202067
12 201958
13 200950
14 202046
15 201144
16 201544
17 200543
18 200743
19 201542
20 201339

About A. Lavolé

A. Lavolé is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 110 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (26 papers), Viral-associated cancers and disorders (26 papers), Lung Cancer Research Studies (17 papers), Cancer Immunotherapy and Biomarkers (15 papers), Lymphoma Diagnosis and Treatment (13 papers), Polyomavirus and related diseases (8 papers) and Colorectal Cancer Treatments and Studies (8 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.1k citations), Virology (84 citations), Genetics (174 citations) and Geriatrics and Gerontology (50 citations). A. Lavolé has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Marie Wislez, Jacques L. Cadranel, Bernard J. Milleron, Valérie Gounant, Anne-Marie Ruppert, Martine Antoine, Jean‐Philippe Spano, Antoine Parrot, Virginie Poulot and Nathalie Rabbe. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology, AIDS and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact